CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study-Reference-Cited by-同舟云学术

CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study

Published:2014-05-15 Issue:10 Volume:56 Page:990-994
ISSN:0012-1622
Container-title:Developmental Medicine & Child Neurology
language:en
Short-container-title:Dev Med Child Neurol

Author:

Youngster Ilan¹,Zachor Ditza A²,Gabis Lidia V³,Bar-Chaim Adina⁴,Benveniste-Levkovitz Patricia⁴,Britzi Malka⁵,Soback Stefan⁵,Ziv-Baran Tomer⁶,Berkovitch Matitiahu¹

Affiliation:

1. Clinical Pharmacology Unit; Assaf Harofeh Medical Center; Zerifin Israel

2. The Autism Center; Assaf Harofeh Medical Center; Zerifin Israel

3. Child Developmental Center; Safra Children's Hospital; Tel Hashomer Israel

4. Pharmacogenetics Laboratory; Assaf Harofeh Medical Center; Zerifin Israel

5. The National Residue Control Laboratory; Ministry of Agriculture; Hebrew University; Jerusalem Israel

6. Department of Epidemiology and Preventive Medicine; School of Public Health; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

Publisher

Wiley

Subject

Clinical Neurology,Developmental Neuroscience,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dmcn.12470/fullpdf

Reference26 articles.

1. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology;McDougle;Am J Psychiatry,2005

2. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders;Shea;Pediatrics,2004

3. Medications for adolescents and young adults with autism spectrum disorders: a systematic review;Dove;Pediatrics,2012

4. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial;Pandina;J Autism Dev Disord,2007

5. The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009;Pringsheim;J Child Adolesc Psychopharmacol,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review;Journal of Psychiatric Research;2024-06

2. The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism;European Journal of Clinical Pharmacology;2024-02-29

3. Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism;Frontiers in Pharmacology;2024-02-05

4. The Frequency of CYP2D6 and CYP3A4/5 Genotypes and The Impact of Their Allele Translation and Phenoconversion-Predicted Enzyme Activity on Risperidone Pharmacokinetics in Saudi Children with Autism;Biochemical Genetics;2023-12-02

5. Risperidone Pharmacogenetics: The Impact of Star Alleles' Predicted Phenotypes on Global Safety in Autistic Children;International Journal of Pharmacology;2023-05-01